E. Beam and R. R. Razonable, Cytomegalovirus in Solid Organ Transplantation: Epidemiology, Prevention, and Treatment, Current Infectious Disease Reports, vol.12, issue.4, pp.633-641, 2012.
DOI : 10.1016/S1473-3099(11)70344-9

C. N. Kotton, D. Kumar, and A. M. Caliendo, Updated International Consensus Guidelines on the Management of Cytomegalovirus in Solid-Organ Transplantation, Transplantation Journal, vol.96, issue.4, pp.333-360, 2013.
DOI : 10.1097/TP.0b013e31829df29d

R. R. Razonable and A. Humar, Cytomegalovirus in Solid Organ Transplantation, American Journal of Transplantation, vol.377, issue.5 Suppl, pp.93-106, 2013.
DOI : 10.1016/S0140-6736(11)60136-0
URL : http://onlinelibrary.wiley.com/doi/10.1111/ajt.12103/pdf

P. Ljungman, M. Boeckh, and H. H. Hirsch, Definitions of cytomegalovirus infection and disease in transplant patients for use in clinical trials, Clinical Infectious Diseases, vol.64, issue.1, pp.87-91, 2017.

L. Couzi, S. Helou, and T. Bachelet, High Incidence of Anticytomegalovirus Drug Resistance Among D+R??? Kidney Transplant Recipients Receiving Preemptive Therapy, American Journal of Transplantation, vol.4, issue.1, pp.202-209, 2012.
DOI : 10.1034/j.1399-3062.2002.t01-1-02008.x
URL : https://hal.archives-ouvertes.fr/hal-00675701

A. K. Le-page, M. M. Jager, J. M. Iwasenko, G. M. Scott, S. Alain et al., Clinical Aspects of Cytomegalovirus Antiviral Resistance in Solid Organ Transplant Recipients, Clinical Infectious Diseases, vol.42, issue.5-6, pp.1018-1029, 2013.
DOI : 10.1159/000053979

R. Lanier, L. Trost, and T. Tippin, Development of CMX001 for the Treatment of Poxvirus Infections, Viruses, vol.2, issue.12, pp.2740-2762, 2010.
DOI : 10.3390/v2122740

E. Justrabo, G. Zanetta, and L. Martin, Irreversible glomerular lesions induced by crystal precipitation in a renal transplant after foscarnet therapy for cytomegalovirus infection, Histopathology, vol.47, issue.4, pp.365-369, 1999.
DOI : 10.1016/0002-9343(69)90208-3

G. Zanetta, L. Maurice-estepa, and C. Mousson, FOSCARNET-INDUCED CRYSTALLINE GLOMERULONEPHRITIS WITH NEPHROTIC SYNDROME AND ACUTE RENAL FAILURE AFTER KIDNEY TRANSPLANTATION, Transplantation, vol.67, issue.10, pp.1376-1378, 1999.
DOI : 10.1097/00007890-199905270-00016

V. Tischler, M. M. Schuurmans, A. Boehler, and A. Gaspert, Crystal precipitation and granulomatous inflammation in multiple organs after foscarnet therapy in a lung transplant recipient, The Journal of Heart and Lung Transplantation, vol.31, issue.9, pp.1037-1040, 2012.
DOI : 10.1016/j.healun.2012.05.008

C. Philipponnet, P. Michel, M. Daudon, I. Brocheriou, and J. Boffa, Intravascular Foscarnet Crystal Precipitation Causing Multiorgan Failure, American Journal of Kidney Diseases, vol.65, issue.1, pp.152-155, 2014.
DOI : 10.1053/j.ajkd.2014.07.024

D. Iwami, Y. Ogawa, and H. Fujita, Successful treatment with foscarnet for ganciclovir-resistant cytomegalovirus infection in a kidney transplant recipient: A case report, Nephrology, vol.9, issue.4, pp.63-66, 2016.
DOI : 10.1159/000167987
URL : http://onlinelibrary.wiley.com/doi/10.1111/nep.12767/pdf

N. S. Lurain and S. Chou, Antiviral Drug Resistance of Human Cytomegalovirus, Clinical Microbiology Reviews, vol.23, issue.4, pp.689-712, 2010.
DOI : 10.1128/CMR.00009-10
URL : http://cmr.asm.org/content/23/4/689.full.pdf

P. West, M. Schmiedeskamp, H. Neeley, J. Oberholzer, E. Benedetti et al., Use of high-dose ganciclovir for a resistant cytomegalovirus infection due to UL97 mutation, Transplant Infectious Disease, vol.12, issue.2, pp.129-132, 2008.
DOI : 10.1128/AAC.49.7.2710-2715.2005

S. Chou, Phenotypic diversity of cytomegalovirus DNA polymerase gene variants observed after antiviral therapy, Journal of Clinical Virology, vol.50, issue.4, pp.287-291, 2011.
DOI : 10.1016/j.jcv.2011.01.004
URL : http://europepmc.org/articles/pmc3059355?pdf=render

S. L. Williams-aziz, C. B. Hartline, and E. A. Harden, Comparative Activities of Lipid Esters of Cidofovir and Cyclic Cidofovir against Replication of Herpesviruses In Vitro, Antimicrobial Agents and Chemotherapy, vol.49, issue.9, pp.3724-3733, 2005.
DOI : 10.1128/AAC.49.9.3724-3733.2005

F. M. Marty, D. J. Winston, and S. D. Rowley, CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation, New England Journal of Medicine, vol.369, issue.13, pp.1227-1236, 2013.
DOI : 10.1056/NEJMoa1303688

D. El-haddad, F. Chaer, and J. Vanichanan, Brincidofovir (CMX-001) for refractory and resistant CMV and HSV infections in immunocompromised cancer patients: A single-center experience, Antiviral Research, vol.134, pp.58-62, 2016.
DOI : 10.1016/j.antiviral.2016.08.024

J. F. Camargo, M. I. Morris, and L. M. Abbo, The use of brincidofovir for the treatment of mixed dsDNA viral infection, Journal of Clinical Virology, vol.83, pp.1-4, 2016.
DOI : 10.1016/j.jcv.2016.07.021

K. M. Mullane, C. Nuss, and J. Ridgeway, Brincidofovir treatment of acyclovir-resistant disseminated varicella zoster virus infection in an immunocompromised host, Transplant Infectious Disease, vol.369, issue.13, pp.785-790, 2016.
DOI : 10.1056/NEJMoa1303688

S. Voigt, J. Hofmann, A. Edelmann, A. Sauerbrei, and J. Kühl, Brincidofovir clearance of acyclovir-resistant herpes simplex virus-1 and adenovirus infection after stem cell transplantation, Transplant Infectious Disease, vol.50, issue.2, pp.791-794, 2016.
DOI : 10.1016/j.jcv.2010.10.016
URL : http://edoc.rki.de/oa/articles/rewtL1lEy8cM/PDF/23Wk9YgakkjiM.pdf

E. , R. Lanier, S. Foster, and T. Brundage, Analysis of mutations in the gene encoding cytomegalovirus DNA polymerase in a phase 2 clinical trial of brincidofovir prophylaxis, Journal of Infectious Diseases, vol.214, issue.1, pp.32-35, 2016.

D. R. Kaul, S. Stoelben, and E. Cober, First Report of Successful Treatment of Multidrug-Resistant Cytomegalovirus Disease with the Novel Anti-CMV Compound AIC246, American Journal of Transplantation, vol.46, issue.5, pp.1079-1084, 2011.
DOI : 10.1086/587106

G. Deray, F. Martinez, and C. Katlama, Foscarnet Nephrotoxicity: Mechanism, Incidence and Prevention, American Journal of Nephrology, vol.9, issue.4, pp.316-321, 1989.
DOI : 10.1159/000167987

L. Maurice-estepa, M. Daudon, and C. Katlama, Identification of crystals in kidneys of AIDS patients treated with foscarnet Submit your manuscripts at https://www, American Journal of Kidney Diseaseshindawi.com Stem Cells International, vol.32, issue.3, pp.392-400, 1998.